aes17

Renee Fortunato (Agency for Clinical Innovation)

NSW Health is shifting to a focus on value rather than volume. Eight Leading Better Value Care programs will be implemented state-wide in 2017/18 with the intention to improve system performance against the Triple Aim; system efficiency, improved health outcomes, and improved patient experience. Existing Agency for Clinical Innovation (ACI) economic evaluations have been critical to inform selection of the eight programs for future investment and scaling up implementation. The monitoring and evaluation approach is currently being designed. The vision is to build a system of monitoring and evaluation including multi-level cascading indicators to guide and measure the program and its impact across relevant system levels.  These levels include health pillar organisations such as ACI, Local Health Districts, hospital, and clinical team levels. This approach seeks to build alignment of functions and focus across numerous components of the NSW Health system to optimise program success.  It also provides an example of how economic evaluation, performance management and incentive systems can intersect to attempt to achieve better program outcomes. 
The purpose of this presentation is to describe how economic evaluation has been an effective tool in increasing investment to scale up implementation of clinical programs across NSW Health. The presenters will share their experience on building a multifaceted approach to monitoring and evaluation to support these eight large system changes and share a program example. Reflections on how evaluation is currently viewed and recognised within this context will also be explored.